Industry leaders to speak at Wood Mackenzie’s European Power & Renewables Conference
Join executives from EDF Energy, Renewable Energy Institute and Société Générale as Europe’s energy sector gears up for critical transformation
LONDON/HOUSTON/SINGAPORE, March 24, 2022 (GLOBE NEWSWIRE) -- This year looks set to define the European power and renewables sector: an energy market that faces dangerously volatile energy prices, fears of 'greenflation' and rising geopolitical risks.
As European and national energy regulators, utilities, solar and wind developers and institutional and private investors determine how the renewables sector can evolve over the next decade to meet ambitious emission reduction targets, Wood Mackenzie will host European energy industry leaders at its European Power & Renewables Conference on April 25-26.
The hybrid in-person and virtual conference will bring together CEOs, policymakers, entrepreneurs, investors, thought leaders and regulators to take stock of the dynamic and critical changes in green energy across Europe and the implications these will have on the renewables sector.
As well as exclusive presentations from Wood Mackenzie experts and a top-tier speaker line-up, including representatives from EDF Energy, Renewable Energy Institute and Société Générale, the European Power & Renewables Conference offers the opportunity to connect with leading developers and utilities. Delegates will also connect with transmission operators, national and European energy regulatory bodies, investment entities and technology providers.
Each day will include a breakout session enabling delegates to connect directly with other attendees, Wood Mackenzie analysts and exhibitors.
Key themes on the agenda include:
- The Perfect Storm: Why 2022 Will be a Pivotal Year for European Power and Renewables
- Can ‘Fit for 55’ and the European Green Deal Deliver: Modelling a Net Zero Economy
- Green Grids and European Cross-Border Transmission: Where is the Opportunity over the Next 10 Years?
- New Roadmap for 2030: What are the Signs Indicating the Need for a European Energy Financing Market Redesign?
- Renewable Capture Prices: Commercial Innovation, Merchant Projects and Key Ways to De-risk the Market
- Focus on Technology Trends in Key Areas of P&R Development in Europe
- New Economics of Offshore Wind: How the Offshore Wind Industry Transitions in the Energy Transition Era
- The Role of Natural Gas in The Energy Transition: Risk, Pricing Dynamics and Opportunity
- Mapping Out the Future for Solar in the European Landscape
The European Power & Renewables Conference will hear from leading experts from across the industry including:
- Matt Black, Chief Operating Officer, Solivus
- Rosalind Smith-Maxwell, Vice President, Quinbrook Infrastructure Partners
- Stephane Tetot, Investment Director, BlackRock Infrastructure
- Tomas Kåberger, Chair of Executive Board, Renewable Energy Institute
- Thomas Fureder, Managing Director, Barclays Investment Bank
- Anthony Doherty, Chief Investment Officer, NTR plc
- Jordi Francesch, Head of Asset Management, Director, Glennmont Partners
- Allan Baker, MD, Global Head of Power Advisory & Project Finance, Société Générale
- Jakob Thomä, Managing Director, 2° Investing Initiative
- Joe Rippon, Sizewell C Financing Programme Manager, EDF Energy
- David Papp, Head of Sustainable Finance Policy Division, Central Bank of Hungary
- Simon Monk, Principal – Structured & Asset Origination, EnBW Energie Baden-Württemberg AG
- Michael Lippert, Director Innovation and Solutions for Energy, SaftBatteries
- Patrick Clerens, Secretary General, The European Association for Storage of Energy (EASE)
- Santiago Bañales, Managing Director of Innovation Middle East (ME), Iberdrola
To reserve your place at Wood Mackenzie’s European Power & Renewables Conference, or for further information, please click on this link.
Wood Mackenzie Event Health & Safety Guidelines/Policies
Wood Mackenzie is committed to providing a safe and healthy environment for all event participants. Our decisions and preventive measures will be guided by the requirements and recommendations of the local health authorities. We are working with the event venue on implementing preventive measures to reduce the potential spread of COVID-19 at the event. Preventive measures include:
- Masks must be worn by all event participants at all times
- Enhanced sanitizing of meeting and exhibit spaces
- Extra venue space to allow for social distancing in meeting space
- Hand sanitizing stations throughout the meeting and exhibit spaces
All Wood Mackenzie policies are subject to change. If changes be made, a notification will be sent to all registered attendees.
About Wood Mackenzie
Wood Mackenzie, a Verisk Analytics business, is a trusted source of commercial intelligence for the world's natural resources sector. We empower clients to make better strategic decisions, providing objective analysis and advice on assets, companies and markets. For more information, visit: www.woodmac.com or follow us on Twitter @WoodMackenzie
WOOD MACKENZIE is a trademark of Wood Mackenzie Limited and is the subject of trademark registrations and/or applications in the European Community, the USA and other countries around the world.
Verisk (Nasdaq:VRSK) provides predictive analytics and decision support solutions to customers in the insurance, energy and specialized markets, and financial services industries. More than 70 percent of the FORTUNE 100 relies on the company’s advanced technologies to manage risks, make better decisions and improve operating efficiency. The company’s analytic solutions address insurance underwriting and claims, fraud, regulatory compliance, natural resources, catastrophes, economic forecasting, geopolitical risks, as well as environmental, social and governance (ESG) matters. Celebrating its 50th anniversary, the company continues to make the world better, safer and stronger, and fosters an inclusive and diverse culture where all team members feel they belong. With more than 100 offices in nearly 35 countries, Verisk consistently earns certification by Great Place to Work.
For more: Verisk.com, LinkedIn, Twitter, Facebook and YouTube.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference16.5.2022 07:00:00 CEST | Press release
GENEVA, Switzerland May16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company Management will provide a corporate update at the upcoming H.C. Wainwright Global Investment Conference, taking place virtually and in Miami, Florida from May 23 – 26, 2022. The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 10:30 a.m. EST on Tuesday, May 24, 2022. A webcast can be accessed here and will also be accessible under “Events Calendar” in the investors section of ObsEva’s website. About ObsEva ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroi
Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease16.5.2022 00:00:00 CEST | Press release
WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration (NMPA) for the initiation of a Phase 1/2 clinical study of ZB001 for the treatment of Thyroid Eye Disease (TED). This study is designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZB001. “The ZB001 IND submission to the NMPA marks a significant milestone for Zenas,” said Hua Mu, MD, PhD, Chief Executive Officer at Zenas. “There are currently no approved therapies for TED patients in China. Treatment options are limited and often involve high doses of steroids associated with serious side effects or surgical intervention. ZB001 has the potential to change the tre
Cool Company Ltd. – Mandatory Notification of Trade15.5.2022 14:52:24 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 13 May 2022 acquired 38,419 shares in the Company at a price of NOK 84.63 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,038,419 shares in the Company, equivalent to 37.59% of the Company’s shares. Please see attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment Primary insider notification form
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 202213.5.2022 18:00:00 CEST | Press release
Monthly information related to total number of voting rights and shares composing the share capital –April 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut(1) voting rights Total of net (2) voting rights December 31, 202131 018 55332 518 33932 515 839January 31, 202231 018 55332 518 33932 515 839February 28, 202231 018 55332 518 54732 516 047March 31, 202231 018 55332 518 54732 516 047April 30, 202231 018 55332 518 54732 516 047 (1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on t
Hövding ansöker om avnotering från Nasdaq First North Growth Market13.5.2022 17:45:00 CEST | Pressemelding
Styrelsen för Hövding Sverige AB (publ) (”Hövding”) har beslutat att ansöka om avnotering av Hövdings aktie från Nasdaq First North Growth Market (”First North”). Sista dag för handel på First North kommer att meddelas efter att Hövding erhållit bekräftelse om detta från Nasdaq. Fosielund Holding AB (”Fosielund”) offentliggjorde genom pressmeddelande den 13 januari 2022 ett offentligt budpliktserbjudande till aktieägarna i Hövding (”Erbjudandet”). Fosielund meddelande genom pressmeddelande den 16 februari 2022 att Fosielund (med närstående), efter redovisning av likvid i Erbjudandet, innehade 18 021 741 aktier motsvarande ca 65 procent av aktierna och rösterna. Den 8 april 2022 meddelade Fosielund genom pressmeddelande att de förvärvat en större post aktier i Hövding, varefter Fosielund innehade ca 88,7 procent av aktierna och rösterna samt en avsikt att förvärva ytterligare aktier. Den 4 maj 2022 meddelade Fosielund genom pressmeddelande att de förvärvat ytterligare aktier och att des